Urology
 |
|
14 november 2019 01:01:07 |
| Efficacy, safety, and tolerability of mirabegron in patients aged >=65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR) (European Urology) |
|
Tweet PILLAR, the first randomised controlled trial of mirabegron in patients with overactive bladder (OAB) aged >=65yr, demonstrated the efficacy of mirabegron for OAB symptoms. The safety and tolerability were consistent with the known safety profile of mirabegron. |
| 211 viewsCategory: Urology |
 The Complexity of Complications: How Do We Estimate Morbidity and Target Improvements Following Radical Cystectomy? (European Urology)Tubeless Supracostal Percutaneous Nephrolithotomy Is Associated With Significantly Less Hydrothorax: A Prospective Randomized Clinical Study (BJU International) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page